Business
Technical, regulatory & commercial update
Technical, regulatory & commercial update.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 0749R OptiBiotix Health PLC 19 September 2017 \n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n \nSlimBiome®: Technical, Regulatory and Commercial Update\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, provides the following technical, regulatory and commercial update on its SlimBiome® product platform.\n \nTechnical Update\n \nOptiBiotix has developed an improved version of SlimBiome® using advanced processing technology which provides the following benefits:-\n \ni. Creating a single homogenous product reducing component separation in transport and improving product consistency. This opens up new application opportunities in areas which lack the ability to blend or remix SlimBiome® (e.g. in store bakeries) \nii. Enhanced solubility giving better product presentation and greatly enhancing flavour and mouthfeel. This improves the taste and consumer experience of products containing SlimBiome® such as 'GoFigure®' shakes and bars\niii. Improved dispersion in water opening up new applications areas to meets demand for 'on the go' products\niv. Lower manufacturing costs due to less waste and more efficient production processes\n \nCommercial and Regulatory Update\n \nOptiBiotix has made significant progress developing and enhancing its pipeline of innovative products with a strong scientific and clinical evidence base. This has attracted commercial interest from a range of manufacturing, retail and corporate partners. Recent commercial developments include:-\n \ni. The Company has obtained FDA registration for both its LP-LDL® and SlimBiome® product ranges allowing access to the US market\nii. The Company will be launching its improved version of SlimBiome® at Supply Side West and exhibiting w...